The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Abstract
When exposed to ionizing radiation (IR), eukaryotic cells activate checkpoint pathways to delay the progression of the cell cycle. Defects in the IR-induced S-phase checkpoint cause 'radioresistant DNA synthesis', a phenomenon that has been identified in cancer-prone patients suffering from ataxia-telangiectasia, a disease caused by mutations in the ATM gene. The Cdc25A phosphatase activates the cyclin-dependent kinase 2 (Cdk2) needed for DNA synthesis, but becomes degraded in response to DNA damage or stalled replication. Here we report a functional link between ATM, the checkpoint signalling kinase Chk2/Cds1 (Chk2) and Cdc25A, and implicate this mechanism in controlling the S-phase checkpoint. We show that IR-induced destruction of Cdc25A requires both ATM and the Chk2-mediated phosphorylation of Cdc25A on serine 123. An IR-induced loss of Cdc25A protein prevents dephosphorylation of Cdk2 and leads to a transient blockade of DNA replication. We also show that tumour-associated Chk2 alleles cannot bind or phosphorylate Cdc25A, and that cells expressing these Chk2 alleles, elevated Cdc25A or a Cdk2 mutant unable to undergo inhibitory phosphorylation (Cdk2AF) fail to inhibit DNA synthesis when irradiated. These results support Chk2 as a candidate tumour suppressor, and identify the ATM-Chk2-Cdc25A-Cdk2 pathway as a genomic integrity checkpoint that prevents radioresistant DNA synthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both Chk1 and Chk2 regulate the functional associations between BRCA1, BRCA2, and Rad51 proteins in response to DNA damage, and thus promote HR-mediated repair of stalled replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
In the citing paper
“Moreover, both the ATR-Chk1 and ATM-Chk2 pathways regulate HR-mediated repair of collapsed replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
In the citing paper
“It has been established that spontaneous HR is promoted by collapsed replication forks that are caused by endogenous DNA SSB [24, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
Citations
Cites
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
The complexity of p53 modulation: emerging patterns from divergent signalsPreprint
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,315
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y., Matsuoka, S., Wakeham, A. C., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,311
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,000
Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity
Berge, E. O., Staalesen, V., Straume, A. H., Lillehaug, J. R., & Lønning, P. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.005 · Cited by 27
Involvement of cell cycle control in bleomycin‐induced mutagen sensitivity
Cloos, J. J., Temmink, O. H., Ceelen, M., Snel, M. H. J., Leemans, C. R., & Braakhuis, B. J. M. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10093 · Cited by 25
Déry, U., & Masson, J. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.009 · Cited by 27
Bahassi, E. M., Penner, C. G., Robbins, S. B., Tichy, E. D., Feliciano, E., Yin, M., Liang, L., Deng, L., Tischfield, J. A., & Stambrook, P. J. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.11.025 · Cited by 26
Tischkowitz, M. D., Yılmaz, A. U., Chen, L. Q., Karyadi, D. M., Novak, D. J., Kirchhoff, T., Hamel, N., Tavtigian, S. V., Kolb, S., Bismar, T. A., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.006 · Cited by 26
On the Slowing of S Phase in Response to DNA Damage in Fission Yeast
Kumar, S., & Huberman, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407819200 · Cited by 25
Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin
Zhang, J., Song, Y., Brannigan, B. W., Wahrer, D. C. R., Schiripo, T. A., Harris, P. L., Haserlat, S. M., Ulkus, L. E., Shannon, K., Garber, J. E., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0033 · Cited by 27
Madlener, S., Rosner, M., Krieger, S., Giessrigl, B., Gridling, M., Vo, T. P. N., Leisser, C., Lackner, A., Raab, I., Grusch, M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp123 · Cited by 24
ATM and Cellular Response to DNA Damage
Lavin, M. F., Kozlov, S., Gueven, N., Peng, C., Birrell, G. W., Chen, P., & Scott, S. P. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_16 · Cited by 24
Zhang, P., Gao, W., Li, H., Reed, E., & Chen, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.007 · Cited by 24
Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex
Kim, K. S., Heo, J., Choi, K. J., & Bae, S. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.962305 · Cited by 24
DNA damage response and hematological malignancy
Takagi, M. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2226-0 · Cited by 24
PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma
Park, M., Yoon, H.-J., Kang, M. C., Kwon, J., & Lee, H. W. (2016) · Tumor Biology · doi:10.1007/s13277-016-5288-3 · Cited by 24
Everything in Moderation: Lessons Learned by Exploiting Moderate Replication Stress in Cancer
Nazareth, D., Jones, M. V., & Gabrielli, B. G. (2019) · Cancers · doi:10.3390/cancers11091320 · Cited by 24
MYBL2 and ATM suppress replication stress in pluripotent stem cells
Blakemore, D., Vilaplana‐Lopera, N., Almaghrabi, R. O. M., Gonzalez, E., Moya, M., Ward, C., Murphy, G. J., Gambus, A., Petermann, E., Stewart, G. S., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051120 · Cited by 25
DNA Damage and Polyploidization
Chow, J. P. H., & Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0_4 · Cited by 24
Chk1–cyclin A/Cdk1 axis regulates origin firing programs in mammals
Nakanishi, M., Katsuno, Y., Niida, H., Murakami, H., & Shimada, M. (2009) · Chromosome Research · doi:10.1007/s10577-009-9086-2 · Cited by 23
Zoppoli, G. M., Solier, S., Reinhold, W. C., Liu, H., Connelly, J. W., Monks, A. P., Shoemaker, R. H., Abaan, O. D., Davis, S. R., Meltzer, P. S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.283 · Cited by 23
Cell cycle-dependent localization of CHK2 at centrosomes during mitosis
Chouinard, G., Clément, I., Lafontaine, J., Rodier, F., & Schmitt, E. (2013) · Cell Division · doi:10.1186/1747-1028-8-7 · Cited by 23
Cyclin D1 promotes BRCA2-Rad51 interaction by restricting cyclin A/B-dependent BRCA2 phosphorylation
Chalermrujinanant, C., Michowski, W., Sittithumcharee, G., Esashi, F., & Jirawatnotai, S. (2015) · Oncogene · doi:10.1038/onc.2015.354 · Cited by 24
The DNA damage response during an unperturbed S-phase
Ben‐Yehoyada, M., Gautier, J., & Dupré, A. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.005 · Cited by 25
Kobayashi, T., Tada, S., Tsuyama, T., Murofushi, H., Seki, M., & Enomoto, T. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3159 · Cited by 23
Mechanism for local attenuation of DNA replication at double-strand breaks
Sebastian, R., Sun, E. G., Fedkenheuer, M., Fu, H., Jung, S., Thakur, B. L., Redon, C. E., Pegoraro, G., Tran, A. D., Gross, J., et al. (2025) · Nature · doi:10.1038/s41586-024-08557-9 · Cited by 22
Koledova, Z. S., Kafkova, L. R., Krämer, A., & Divoký, V. (2010) · Stem Cells · doi:10.1002/stem.311 · Cited by 26
Ngoi, N. Y. L., Westin, S. N., & Yap, T. A. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000867 · Cited by 23
Seedhouse, C., Grundy, M. A., Shang, S., Ronan, J., Pimblett, H., Russell, N. H., & Pallis, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1222 · Cited by 22
Koch, B., Maser, E., & Hartwig, A. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2004-z · Cited by 23
Cyclin dependent kinases as targets for cancer therapy
Shah, M. A., & Schwartz, G. K. (2006) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2006.08.001 · Cited by 22
The Fanconi anemia protein interaction network: Casting a wide net
Rego, M. A., Kolling, F. W., & Howlett, N. G. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.018 · Cited by 22
Krupitza, G. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000403 · Cited by 22
High frequency induction of mitotic recombination by ionizing radiation in Mlh1 null mouse cells
Wang, Q., Ponomareva, O. N., Lasarev, M. R., & Turker, M. S. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.09.005 · Cited by 22
Cao, Y., Chen, S., Lu, J., Zhang, M., Shi, L., Qin, J., Lv, J., Li, D., Ma, L., & Zhang, Y. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-26850-4 · Cited by 21
Liang, X., Guo, Y., Figg, W. D., Fojo, A. T., Mueller, M. D., & Yu, J. (2010) · Chemotherapy Research and Practice · doi:10.1155/2011/715469 · Cited by 23
Yang, V. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00008-6 · Cited by 24
Regulation of Cdc25A Half-life in Interphase by Cyclin-dependent Kinase 2 Activity
Ducruet, A. P., & Lazo, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303604200 · Cited by 21
Differential Expression of Genes Induced by Resveratrol in Human Breast Cancer Cell Lines
Corre, L. L., Chalabi, N., Delort, L., Bignon, Y., & Bernard-Gallon, D. J. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5602_10 · Cited by 21
TopBP1-mediated DNA processing during mitosis
Gallina, I., Christiansen, S. K., Pedersen, R. T., Lisby, M., & Oestergaard, V. H. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1128595 · Cited by 22
Zhao, H., Chen, X., Gurian-West, M., & Roberts, J. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06721-11 · Cited by 21
Wang, L., Dai, W. H., & Lu, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.597161 · Cited by 20
ATM in focus: A damage sensor and cancer target
Khalil, H. S., Tummala, H., & Zhelev, N. (2012) · Biodiscovery · doi:10.7750/biodiscovery.2012.5.1 · Cited by 23
Li, Z., Wang, F., Qian, C., Neumann, R. M., Cheville, J. C., Tindall, D. J., & Liu, W. (2006) · Human Mutation · doi:10.1002/humu.9457 · Cited by 21
Integrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts
Barkley, L. R., Ohmori, H., & Vaziri, C. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0032-7 · Cited by 20
FM19G11: A new modulator of HIF that links mTOR activation with the DNA damage checkpoint pathways
Rodríguez-Jiménez, F. J., Moreno‐Manzano, V., Mateos-Gregorio, P., Royo, I., Erceg, S., Murguía, J. R., & Sánchez-Puelles, J.-M. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12250 · Cited by 21
Checkpoint and Coordinated Cellular Responses to DNA Damage
Yang, X. H., & Zou, L. (2006) · Springer eBooks · doi:10.1007/b136684 · Cited by 20
Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico
Dutil, J., Teer, J. K., Golubeva, V. A., Yoder, S., Tong, W. L., Arroyo, N., Karam, R., Echenique, M. M., Matta, J. L., & Monteiro, Á. N. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-54170-6 · Cited by 19
Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation Resistance
Thielhelm, T. P., Goncalves, S., Welford, S. M., Mellon, E. A., Cohen, E. R., Nourbakhsh, A., Fernández‐Valle, C., Telischi, F. F., Ivan, M. E., & Dinh, C. T. (2021) · Cancers · doi:10.3390/cancers13184575 · Cited by 19
Wang, Z., Wang, M., Kar, S., & Carr, B. I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21844 · Cited by 19
A Stronger DNA Damage-Induced G2 Checkpoint Due to Over-Activated CHK1 in the Absence of PARP-1
Lu, H., Wang, X., & Wang, Y. (2006) · Cell Cycle · doi:10.4161/cc.5.20.3355 · Cited by 21
Mammalian DNA Damage Response Pathway
Lou, Z., & Chen, J. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_15 · Cited by 19
Xavier, S., MacDonald, S., Roth, J., Caunt, M., Akalu, A., Morais, D., Buckley, M. T., Liebes, L., Formenti, S. C., & Brooks, P. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.010 · Cited by 19
Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences
Dedobbeleer, M., Willems, E., Freeman, S. D., Lombard, A., Goffart, N., & Rogister, B. (2017) · Biochemical Journal · doi:10.1042/bcj20170112 · Cited by 19
Another twist in the transforming growth factor β-induced cell-cycle arrest chronicle
Denicourt, C., & Dowdy, S. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307282100 · Cited by 19
Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk
Varley, J. M., & Haber, D. A. (2003) · Breast Cancer Research · doi:10.1186/bcr582 · Cited by 19
Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman, Y., Kaufman, B., Levy‐Lahad, E., Papa, M. Z., & Friedman, E. (2007) · PubMed · Cited by 19
Sagata, N. (2002) · Science · doi:10.1126/science.1079225 · Cited by 19
Radiation-induced intestinal injury: from molecular mechanisms to clinical translation
Wu, W., Cai, Y., Yang, Z., Chen, M., Hu, J., Qu, K., & Yang, J. (2025) · Oncology Reviews · doi:10.3389/or.2025.1613704 · Cited by 18
Ashraf, S., Deshpande, N. R., Cheung, Q., Boakye, J., Wong, R. K., Gauthier, A. G., Parekh, M., Adhikari, Y., Melangath, G., & Jurkunas, U. V. (2024) · Communications Biology · doi:10.1038/s42003-024-07179-1 · Cited by 20
Mammary Tumorigenesis following Transgenic Expression of a Dominant Negative CHK2 Mutant
Kwak, E. L., Kim, S., Zhang, J., Cardiff, R. D., Schmidt, E. V., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1237 · Cited by 18
Absence of CHEK2 mutations in Spanish families with hereditary breast cancer
Bellosillo, B., Tusquets, I., Longarón, R., Pérez-Lezaun, A., Bellet, M., Fabregat, X., Serrano, S., & Solé, F. G. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.01.016 · Cited by 19
Shreeram, S., Hee, W. K., & Bulavin, D. V. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00138-08 · Cited by 17
Brunetto, E., Ferrara, A. M., Rampoldi, F., Talarico, A., Cin, E. D., Grassini, G., Spagnuolo, L., Sassi, I., Ferro, A., Cuorvo, L. V., et al. (2013) · Neoplasia · doi:10.1593/neo.122054 · Cited by 17
Jang, E. R., Lee, J. H., Lim, D., & Lee, J. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0522-y · Cited by 17
Kshirsagar, M. P., Jiang, W., & Shih, I. (2011) · Journal of Oncology · doi:10.1155/2012/621685 · Cited by 17
Chek2 DNA Damage Response Pathway and Inherited Breast Cancer Risk
Tung, N., & Silver, D. P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.1476 · Cited by 17
Checkpoint regulation of replication forks: global or local?
Iyer, D., & Rhind, N. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130197 · Cited by 18
Intratracheal administration of fullerene nanoparticles activates splenic CD11b+ cells
Ding, N., Kunugita, N., Ichinose, T., Song, Y., Yokoyama, M., Arashidani, K., & Yoshida, Y. (2011) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2011.07.101 · Cited by 17
Mitotic Oscillators as MP Graphs
Franco, G., Guzzi, P. H., Manca, V., & Mazza, T. (2006) · Lecture notes in computer science · doi:10.1007/11963516_24 · Cited by 17
Pike, B. L., Tenis, N., & Heierhorst, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405080200 · Cited by 17
Replicating Damaged DNA in EukaryotesPreprint
Chatterjee, N., & Siede, W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019836 · Cited by 17
Genome instability and Rad50S: subtle yet severePreprint
de Jager, M., & Kanaar, R. (2002) · Genes & Development · doi:10.1101/gad.1025402 · Cited by 17
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants
Stubbins, R. J., Arnovitz, S., Vagher, J., Asom, A. S., Perpich, M., Pies, M., Akpan, I. J., Chew, E., Bridgers, J., Karsan, A., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02635-1 · Cited by 16
Satapathy, S., Das, C. K., Aggarwal, P., Sood, A. K., Parihar, A. S., Singh, S. K., & Mittal, B. R. (2022) · The Prostate · doi:10.1002/pros.24450 · Cited by 16
Cangi, M. G., Piccinin, S., Pecciarini, L., Talarico, A., Cin, E. D., Grassi, S., Grizzo, A., Maestro, R., & Doglioni, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23659 · Cited by 16
Tantos, Á., Kalmár, L., & Tompa, P. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1042866 · Cited by 16
DNA damage response is hijacked by human papillomaviruses to complete their life cycle
Hong, S.-Y. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600306 · Cited by 17
Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation
Shen, T., Zhou, H., Shang, C., Luo, Y., Wu, Y., & Huang, S. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.166 · Cited by 16
Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy
Li, L., Kumar, A. K., Hu, Z., & Guo, Z. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200224102309 · Cited by 17
Obesity alters the ovarian DNA damage response and apoptotic proteins
Clark, K. L., Roach, C. M., & Keating, A. F. (2020) · Reproduction · doi:10.1530/rep-20-0070 · Cited by 16
Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0 · Cited by 16
Involvement of protein kinase PKN1 in G2/M delay caused by arsenite
Isagawa, T., Takahashi, M., Kato, T., Mukai, H., & Ono, Y. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20087 · Cited by 16
Zhou, T., Chou, J.-H., Zhou, Y., Simpson, D. A., Cao, F., Bushel, P. R., Paules, R. S., & Kaufmann, W. K. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0104 · Cited by 16
Cdc2 Tyrosine Phosphorylation is Not Required for the S-Phase DNA Damage Checkpoint in Fission Yeast
Kommajosyula, N., & Rhind, N. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3423 · Cited by 16
Mamon, H. J., Dahlberg, W. K., Azzam, E. I., Nagasawa, H. T., Muto, M. G., & Little, J. B. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001610952 · Cited by 16
Vanan, I., Dong, Z., Tosti, E., Warshaw, G., Symons, M. H., & Ruggieri, R. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9846-y · Cited by 15
Central Role of Ubiquitination in Genome Maintenance: DNA Replication and Damage Repair
Ghosh, S., & Saha, T. (2012) · ISRN Molecular Biology · doi:10.5402/2012/146748 · Cited by 15
Autophosphorylated Residues Involved in the Regulation of Human Chk2 In Vitro
Gabant, G., Lorphelin, A., Nozerand, N., Marchetti, C., Bellanger, L., Dedieu, A., Quéméneur, É., & Alpha‐Bazin, B. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.053 · Cited by 17
Hebeisen, M., Drysdale, J., & Roy, R. (2008) · RNA · doi:10.1261/rna.1168408 · Cited by 15
Cell-cycle Alterations in Post-mitotic Cells and Cell Death by Mitotic Catastrophe
Lombardi, D., & Lasagni, L. (2016) · InTech eBooks · doi:10.5772/61783 · Cited by 16
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment
Rozpędek‐Kamińska, W., Pytel, D., Nowak-Zduńczyk, A., Lewko, D., Wojtczak, R., Diehl, J. A., & Majsterek, I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180117102233 · Cited by 15
Regulatory functional territory of PLK-1 and their substrates beyond mitosis
Kumar, S., Sharma, G., Chakraborty, C., Sharma, A. R., & Kim, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16290 · Cited by 15
Chromosomal radiosensitivity of breast cancer with a mutation
Baeyens, A., Claes, K., Willems, P. H. G. M., DERUYCK, K., Thierens, H. M., & Vral, A. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.04.017 · Cited by 15
Beardsley, D. I., Kim, W.-J., & Brown, K. D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013888 · Cited by 15
Wagener, R., Walter, C., Auer, F., Alzoubi, D., Hauer, J., Fischer, U., Varghese, J., Dugas, M., Borkhardt, A., & Brozou, T. (2022) · International Journal of Cancer · doi:10.1002/ijc.34390 · Cited by 14
Qin, S., Kitty, I., Hao, Y., Zhao, F., & Kim, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210212 · Cited by 14
Gu, H., Qiu, W., Wan, Y., Ding, G., Tang, W., Liu, C., Shi, Y., Chen, Y., & Chen, S. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1410-1 · Cited by 14
Pauty, J., Côté, M., Rodrigue, A., Velic, D., Masson, J., & Fortin, S. (2016) · Scientific Reports · doi:10.1038/srep23302 · Cited by 14
Nomura, D., Abe, R., & Tsukimoto, M. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00934 · Cited by 14
Chou, S.-T., Yen, Y., Lee, C., & Chen, M.-S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078386 · Cited by 14
Checkpoint Regulation of DNA Replication
Boye, E., Skjølberg, H. C., & Grallert, B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-815-7_4 · Cited by 17
Liu, Y., Xu, Y., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., & Xie, Y. (2015) · BMC Cancer · doi:10.1186/s12885-015-1203-3 · Cited by 14
Metadata
- Authors
- Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J.
- Affiliations
- Danish Cancer Society (DK)
- Venue
- Nature
- Published
- 2001-04
- Volume
- 410
- Issue
- 6830
- Pages
- 842-847
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1480741751
- Cited by
- 1,085
- References
- 30
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 22 · 2023: 20 · 2022: 24 · 2021: 29 · 2020: 19 · 2019: 31 · 2018: 24 · 2017: 30 · 2016: 40 · 2015: 30 · 2014: 37 · 2013: 43 · 2012: 55
- FWCI
- 29.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- radioresistant DNA synthesis, ATM, Chk2, CDC25A, CDK2, S-phase checkpoint, ionizing radiation, DNA damage response, tumour suppressor, ataxia telangiectasia, DNA replication inhibition, protein phosphorylation
- MeSH terms
- Alleles, Animals, Cell Cycle, Cell Line, DNA Replication, DNA-Binding Proteins, Humans, Phosphorylation, Protein Kinases, Radiation Tolerance, Radiation, Ionizing, Serine, Transfection, Signal Transduction, S Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, cdc25 Phosphatases, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review